HomeStocksMISHTANN

M

Mishtann Foods

MISHTANN Share Price

Food Products

5.08

0.01 (0.20%) profit

as on 18 Mar 2025 at 15:51

1D

BSE

MISHTANN Latest News

Life Insurance Corporation of India: Seeks 100-Year Bonds, Explores Health Insurance Stake

sentiment_img

LIC CEO Siddhartha Mohanty urges RBI to introduce ultra-long-term government bonds, including 100-year securities. LIC is in final stages of acquiring a stake in a health insurance company, with a deal expected before March 31. The life insurance sector faces challenges, with industry growth slowing down.

1 hours ago

Zydus Lifesciences: FDA Approves Generic Prostate Cancer Drug

sentiment_img

Zydus Lifesciences received final FDA approval for apalutamide tablets, a generic version of Erleada, used to treat metastatic castration-sensitive prostate cancer. The drug had annual US sales of $1099.8 million as of January 2025. Zydus now has 420 FDA approvals.

2 hours ago

Hero MotoCorp: Market Share Decline Amid Rising Competition

sentiment_img

Hero MotoCorp's stock is down 43% from its peak, trading at multi-month lows. The company faces challenges including a slowdown in two-wheeler sales, declining market share, and increased competition, especially from Honda. Hero's domestic market share dropped to 28.52%, while Honda's rose to 24.27%. The company is shifting focus to premium motorcycles and EVs to counter these challenges.

2 hours ago

Life Insurance Corporation of India: LIC Requests RBI for 100-Year Government Bonds

sentiment_img

LIC has asked the Reserve Bank of India to introduce long-term government bonds, including 100-year bonds, to match their whole life policies. The RBI currently allows up to 40-year bonds. LIC is actively investing in G-secs, subscribing to over 20% of issuances.

3 hours ago

Macquarie Sees Potential for Lemon Tree Hotels to Double Value

sentiment_img

Macquarie, a financial services firm, has issued a positive outlook for Lemon Tree Hotels. According to their analysis, the company has the potential to double its value at a 1x PEG (Price/Earnings to Growth) ratio. This suggests that Macquarie believes Lemon Tree Hotels' stock is currently undervalued relative to its expected earnings growth.

7 hours ago

Macquarie Maintains Outperform Rating on Lemon Tree Hotels

sentiment_img

Macquarie, a financial services firm, has maintained an 'Outperform' rating on Lemon Tree Hotels with a target price of Rs 210 per share. This suggests a positive outlook for the company's stock performance.

7 hours ago

MM Forgings: Potential $5 Million Sales Impact from US Emissions Policy Shift

sentiment_img

MM Forgings estimates a potential $5 million sales hit if US EPA rolls back auto emissions requirements. The company views this as a temporary setback, expecting long-term shift towards greener standards. Chairman Vidyashankar Krishnan sees possible pre-buy boost in 2026 if norms proceed, or evened-out demand if delayed. MM Forgings plans to gain market share in stable European heavy truck industry.

8 hours ago

Tata Consultancy Services: Citi Cuts Target Price Amid Economic Uncertainty

sentiment_img

Citi reduced TCS target price to Rs 3,205 from Rs 3,900, maintaining 'sell' rating. Valuation multiple lowered to 22x from 28x due to macroeconomic uncertainty. TCS earnings projected to grow at 5% annually over FY2024-26. Nifty IT index in bear market, down 20.51% since December 2024.

8 hours ago

Corporate Actions

No Data

Sorry, No Corporate Actions at this Moment!


What’s New In The Market
icon
L

Life Insurance Corporation of India: Seeks 100-Year Bonds, Explores Health Insurance Stake

sentiment_img

LIC CEO Siddhartha Mohanty urges RBI to introduce ultra-long-term government bonds, including 100-year securities. LIC is in final stages of acquiring a stake in a health insurance company, with a deal expected before March 31. The life insurance sector faces challenges, with industry growth slowing down.

1 hours ago

icon
Z

Zydus Lifesciences: FDA Approves Generic Prostate Cancer Drug

sentiment_img

Zydus Lifesciences received final FDA approval for apalutamide tablets, a generic version of Erleada, used to treat metastatic castration-sensitive prostate cancer. The drug had annual US sales of $1099.8 million as of January 2025. Zydus now has 420 FDA approvals.

2 hours ago

icon
H

Hero MotoCorp: Market Share Decline Amid Rising Competition

sentiment_img

Hero MotoCorp's stock is down 43% from its peak, trading at multi-month lows. The company faces challenges including a slowdown in two-wheeler sales, declining market share, and increased competition, especially from Honda. Hero's domestic market share dropped to 28.52%, while Honda's rose to 24.27%. The company is shifting focus to premium motorcycles and EVs to counter these challenges.

HEROMOTOCO

3,564.65

71.55
(2.05%) profit
2 hours ago

icon
L

Life Insurance Corporation of India: LIC Requests RBI for 100-Year Government Bonds

sentiment_img

LIC has asked the Reserve Bank of India to introduce long-term government bonds, including 100-year bonds, to match their whole life policies. The RBI currently allows up to 40-year bonds. LIC is actively investing in G-secs, subscribing to over 20% of issuances.

3 hours ago

icon
L

Macquarie Sees Potential for Lemon Tree Hotels to Double Value

sentiment_img

Macquarie, a financial services firm, has issued a positive outlook for Lemon Tree Hotels. According to their analysis, the company has the potential to double its value at a 1x PEG (Price/Earnings to Growth) ratio. This suggests that Macquarie believes Lemon Tree Hotels' stock is currently undervalued relative to its expected earnings growth.

7 hours ago

icon
L

Macquarie Maintains Outperform Rating on Lemon Tree Hotels

sentiment_img

Macquarie, a financial services firm, has maintained an 'Outperform' rating on Lemon Tree Hotels with a target price of Rs 210 per share. This suggests a positive outlook for the company's stock performance.

7 hours ago

icon
M

MM Forgings: Potential $5 Million Sales Impact from US Emissions Policy Shift

sentiment_img

MM Forgings estimates a potential $5 million sales hit if US EPA rolls back auto emissions requirements. The company views this as a temporary setback, expecting long-term shift towards greener standards. Chairman Vidyashankar Krishnan sees possible pre-buy boost in 2026 if norms proceed, or evened-out demand if delayed. MM Forgings plans to gain market share in stable European heavy truck industry.

8 hours ago

icon
T

Tata Consultancy Services: Citi Cuts Target Price Amid Economic Uncertainty

sentiment_img

Citi reduced TCS target price to Rs 3,205 from Rs 3,900, maintaining 'sell' rating. Valuation multiple lowered to 22x from 28x due to macroeconomic uncertainty. TCS earnings projected to grow at 5% annually over FY2024-26. Nifty IT index in bear market, down 20.51% since December 2024.

TCS

3,552.45

54.75
(1.57%) profit
8 hours ago
Candle bars with Screen
Invest in MISHTANN
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India.
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client in the chat section are for support purposes only, and any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Saarthi 2.0 Mobile App for Investors